FineMark National Bank & Trust’s KYTHERA BIOPHARMACEUTICALS, INC COM KYTH Stock Holding History

FineMark National Bank & Trust’s Portfolio KYTH Stock Details KYTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-1,000	Closed	-$75K	–	1567
2015 Q3	$75K	Sell	1,000 -1,000	-50%	-$74.7K	0.01%	525
2015 Q2	$151K	Hold	2,000	–	–	0.02%	389
2015 Q1	$100K	Hold	2,000	–	–	0.01%	488
2014 Q4	$69K	Hold	2,000	–	–	0.01%	581
2014 Q3	$66K	Buy	+2,000	New	+$70.4K	0.01%	567

FineMark National Bank & Trust's KYTH Position: Q4 2015 in Review

FineMark National Bank & Trust sold out of KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) in Q4 2015, closing a stake of 1,000 shares — an estimated $75K sold.

FineMark National Bank & Trust first reported a position in KYTH in Q3 2014 and held it in 5 quarters. The position peaked at $151K in Q2 2015. 0 funds tracked by Wall St. Rank hold KYTH as of Q4 2015.

FineMark National Bank & Trust reported no remaining KYTHERA BIOPHARMACEUTICALS, INC COM position as of Q4 2015 after selling out during the quarter.
FineMark National Bank & Trust sold 1,000 KYTHERA BIOPHARMACEUTICALS, INC COM shares in Q4 2015, an estimated $75K.
FineMark National Bank & Trust first reported a position in KYTHERA BIOPHARMACEUTICALS, INC COM in Q3 2014 and held it in 5 quarters.
FineMark National Bank & Trust's KYTHERA BIOPHARMACEUTICALS, INC COM position peaked at $151K in Q2 2015.
0 funds tracked by Wall St. Rank held KYTHERA BIOPHARMACEUTICALS, INC COM as of Q4 2015.

Based on FineMark National Bank & Trust's 13F filing for Q4 2015, filed 9 Feb 2016.